Ann Surg Oncol
- SHIMIZU H, Kurashima K, Fukami T, Shiozaki A, et al
Functional Analysis and Clinical Significance of Glutaredoxin 2 in Colon Cancer.
Ann Surg Oncol. 2025 Jun 5. doi: 10.1245/s10434-025-17404.
- TSAGKALIDIS V, Handorf EA, Bates BA, Brauer DG, et al
ASO Visual Abstract: Estimating the Survival Impact of Curative-Intent Liver
Therapies for Colorectal Cancer Liver Metastases.
Ann Surg Oncol. 2025 Jun 5. doi: 10.1245/s10434-025-17620.
- SHIMIZU H, Kurashima K, Fukami T, Shiozaki A, et al
ASO Visual Abstract: Functional Analysis and Clinical Significance of
Glutaredoxin 2 in Colon Cancer.
Ann Surg Oncol. 2025 Jun 3. doi: 10.1245/s10434-025-17582.
- TAQI K, Icchhpuniani S, Stockley C, Elmi Assadzadeh G, et al
ASO Visual Abstract: Outcomes of Cytoreductive Surgery and Hyperthermic
Intraperitoneal Chemotherapy (CRS & HIPEC) and Liver-Directed Therapy for
Synchronous Peritoneal and Liver Metastatic Colorectal Cancer: A Systematic
Review with Meta-analysis.
Ann Surg Oncol. 2025 Jun 2. doi: 10.1245/s10434-025-17569.
- LOEHRER AP, Wang Q, O'Malley AJ, Wong SL, et al
ASO Visual Abstract: Influence of Medicaid Expansion on Rural Medicare
Beneficiaries Undergoing Colon-Cancer-Directed Surgery in the United States.
Ann Surg Oncol. 2025 May 31. doi: 10.1245/s10434-025-17469.
- RAICHURKAR P, Brown KGM, White K, Koh CE, et al
Undergoing Cytoreductive Surgery for Colorectal Peritoneal Metastases: A
Qualitative Exploration of the Lived Experiences of Patients and Carers.
Ann Surg Oncol. 2025;32:5042-5050.
- PEREZ RO, Vailati BB, Sao Juliao GP, Mazzucato F, et al
The Landmark Series: Organ Preservation in Rectal Cancer-The Watch and Wait
Strategy.
Ann Surg Oncol. 2025;32:4945-4956.
- BUNJO Z, Sammour T
The Landmark Series: Neoadjuvant Therapy for Locally Advanced Rectal Cancer.
Ann Surg Oncol. 2025;32:4935-4944.
- ZIVANOV CN, Kau NS, Nalluri-Butz H, Oduyale OK, et al
Nonoperative Management of Rectal Cancer: Is "Near-Complete" Response Safe to
Surveil?
Ann Surg Oncol. 2025;32:4922-4930.
BMC Cancer
- WANG Y, Lu J, Huang D, Chen P, et al
Explosive tumor growth in a patient with colon cancer is associated with reduced
neoantigen levels and decreased interferon-gamma (IFN-gamma) signaling.
BMC Cancer. 2025;25:1005.
- VAHED IE, Moshgelgosha M, Kor A, Minadi M, et al
The role of Adiponectin and Leptin in Colorectal Cancer and Adenoma: a systematic
review and meta-analysis.
BMC Cancer. 2025;25:968.
- MA A, Zhai C, He Q, Wang W, et al
ENTR1 affects the progression of colon cancer by regulating energy metabolism
under the influence of glycolysis.
BMC Cancer. 2025;25:992.
- SABERPOUR M, Maqsoodi R, Bakhshi B
Anti-cancer properties of chitosan /Lactobacillus acidophilus secretome
nanoparticle on signaling pathways of colorectal cancer in colon adenocarcinoma
(Caco-2) cell line.
BMC Cancer. 2025;25:983.
- ZENG Z, Ke Y, Huang F, Li H, et al
Targeting INF2 with DiosMetin 7-O-beta-D-Glucuronide: a new stratagem for colorectal
cancer therapy.
BMC Cancer. 2025;25:982.
- XIE X, Wang W, Zhang H, Zhao S, et al
Cholesterol-induced colorectal cancer progression and its mitigation through gut
microbiota remodeling and simvastatin treatment.
BMC Cancer. 2025;25:977.
BMC Gastroenterol
- LV J, Chen Q, Yang L, Guan J, et al
Comparative serum imidazole propionate profiling in colorectal adenoma and cancer
by UPLC-MS/MS.
BMC Gastroenterol. 2025;25:426.
Cancer Lett
- SUN Z, Wu R, Liang X, Shi T, et al
MLCK inhibition induces synthetic lethality in MYC-driven cancer.
Cancer Lett. 2025;625:217803.
- MIDDE A, Arri N, Kristian T, Mukherjee S, et al
Corrigendum to "Targeting mitochondrial ribosomal protein expression by
andrographolide and melatonin for colon cancer treatment" [Cancer Lett. 619
(2025) 1-11 217647].
Cancer Lett. 2025 May 30:217784. doi: 10.1016/j.canlet.2025.217784.
Gastroenterology
- LIU J
Is the Molecular Classification of ERBB2 in Stage III Colon Cancer Clinically
Ready?
Gastroenterology. 2025 Jun 3:S0016-5085(25)00839.
Gastrointest Endosc
- CHANDAN S
Endoscopic Approaches to Reduce the Incidence of Interval Colon Cancer.
Gastrointest Endosc. 2025 May 28:S0016-5107(25)01701.
Gut
- SOUNDARARAJAN R, Halade G, Yeatman TJ
Response to the letter to the editor 'revisiting lipid dysregulation in
colorectal cancer: critical appraisal of pro-inflammatory bias and therapeutic
implications'.
Gut. 2025 Jun 4:gutjnl-2025-335452. doi: 10.1136/gutjnl-2025-335452.
- ZHANG Y, Song W, Zhou L, Wei S, et al
Bacteria-metabolite butyrate boosts anti-PD1 efficacy in colorectal cancer
patient-derived organoids through activating autologous tumour-infiltrating GNLY
(+)CD8(+) T cells.
Gut. 2025 Jun 1:gutjnl-2025-335306. doi: 10.1136/gutjnl-2025-335306.
Int J Cancer
- KORSGAARD U, Kristensen MP, Garcia-Rodriguez JL, Kjaer-Frifeldt S, et al
The prognostic potential of RNA in stage II colon cancer: Insights from a
screened multicenter population-based cohort study.
Int J Cancer. 2025 Jun 6. doi: 10.1002/ijc.35507.
Int J Colorectal Dis
- HARA K, Chikaishi W, Yamada Y, Fujii H, et al
Geriatric 8 score as a prognostic factor of the efficacy and safety of
oxaliplatin-based chemotherapy in elderly patients with metastatic colorectal
cancer.
Int J Colorectal Dis. 2025;40:132.
J Natl Cancer Inst
-
Correction to: Survival in Young-Onset Metastatic Colorectal Cancer: Findings
From Cancer and Leukemia Group B (Alliance)/SWOG 80405.
J Natl Cancer Inst. 2025 May 30:djaf124. doi: 10.1093.
- OVEISI N, Sayre EC, Brotto LA, Cheng V, et al
Sexual health outcomes after colorectal cancer diagnosis in females: a
population-based cohort study.
J Natl Cancer Inst. 2025 Jun 1:djaf120. doi: 10.1093.
J Surg Oncol
- EMILE SH, Horesh N, Garoufalia Z, Gefen R, et al
Development and Validation of a Predictive Score for Preoperative Detection of
Lymphovascular Invasion in Rectal Cancer.
J Surg Oncol. 2025;131:1081-1089.
- HENDRICK LE, Naffouje S, Imanirad I, Pereira AL, et al
Incomplete?Resection?Is?Twice as Likely in Locally Advanced Mucinous?Compared
to?Nonmucinous?Rectal Adenocarcinoma: A National Propensity-Matched Analysis.
J Surg Oncol. 2025;131:1090-1100.
- NADARAJAN AR, Krishnan Nair C, Muralee M, Wagh MS, et al
Outcomes of Minimally Invasive Rectal Cancer Resection: Insights From a
Resource-Limited Setting.
J Surg Oncol. 2025;131:1101-1109.
- BALLAL DS, Saklani AP
Evidence-Based De-Escalation of Radiotherapy in Locally Advanced Rectal Cancer.
J Surg Oncol. 2025;131:983-987.
- BAKILLAH E, Rosenthal JW, Syvyk S, Wirtalla C, et al
The Burden of Colorectal Cancer Treatment on Quality of Life: A Paired
Longitudinal Analysis of Medicare Advantage Enrollees.
J Surg Oncol. 2025 Jun 2. doi: 10.1002/jso.28161.
Lancet Oncol
- GILBERT A, Adams R, Webster J, Gilbert DC, et al
Standard versus reduced-dose chemoradiotherapy in anal cancer (PLATO-ACT4):
short-term results of a phase 2 randomised controlled trial.
Lancet Oncol. 2025;26:707-718.
N Engl J Med
- COURNEYA KS, Vardy JL, O'Callaghan CJ, Gill S, et al
Structured Exercise after Adjuvant Chemotherapy for Colon Cancer.
N Engl J Med. 2025 Jun 1. doi: 10.1056/NEJMoa2502760.
- ELEZ E, Yoshino T, Shen L, Lonardi S, et al
Encorafenib, Cetuximab, and mFOLFOX6 in BRAF-Mutated Colorectal Cancer.
N Engl J Med. 2025 May 30. doi: 10.1056/NEJMoa2501912.
Oncogene
- GUO ST, Jiang CC, Wang GP, Li YP, et al
Correction: MicroRNA-497 targets insulin-like growth factor 1 receptor and has a
tumour suppressive role in human colorectal cancer.
Oncogene. 2025 Jun 3. doi: 10.1038/s41388-025-03446.
- GU J, Xu X, Li X, Yue L, et al
Correction: Tumor-resident microbiota contributes to colorectal cancer liver
metastasis by lactylation and immune modulation.
Oncogene. 2025 Jun 2. doi: 10.1038/s41388-025-03439.
- QU S, Feng B, Xing M, Qiu Y, et al
PRMT5 K240lac confers ferroptosis resistance via ALKBH5/SLC7A11 axis in
colorectal cancer.
Oncogene. 2025 May 30. doi: 10.1038/s41388-025-03457.
Proc Natl Acad Sci U S A
- IGUCHI E, Takai A, Oe N, Fujii Y, et al
Epithelial Regnase-1 inhibits colorectal tumor growth by regulating IL-17
signaling via degradation of NFKBIZ mRNA.
Proc Natl Acad Sci U S A. 2025;122:e2500820122.
World J Surg
- GIANNONE F, Sangiuolo F, Cassese G, Palucci M, et al
The Impact of KRAS Status on Long-Term Outcomes After Thermal Ablation and
Hepatic Resection for Liver-Only Colorectal Metastases: A New Clue for Tailoring
Surgical Strategy on Tumor Biology?
World J Surg. 2025;49:1573-1582.
Free Medical Abstracts
Privacy Policy
Sponsors
Share
© Amedeo 1997-2016